Dyslipidemia and Kidney: An Updated View

Journal Title: Journal of European Internal Medicine Professionals (JEIMP) - Year 2024, Vol 2, Issue 1

Abstract

Dyslipidemia is a common concern in various kidney-related conditions, including chronic kidney disease, nephrotic syndrome, kidney transplant patients, and those undergoing dialysis. Dyslipidemia is a significant risk factor for atherosclerosis and cardiovascular diseases in these patient groups. Understanding the unique challenges and factors associated with dyslipidemia in these kidney-related conditions is essential for providing effective patient care and reducing cardiovascular risk. This review explores the relationship between dyslipidemia and kidney diseases, highlighting the key recommendations and considerations for managing lipid profiles in each population.

Authors and Affiliations

Özgür Can University of Health Sciences, Istanbul Haydarpaşa Numune Training and Research Hospital, Department of Nephrology, Istanbul, Turkey https://orcid. org/0000-0001-8720-1400

Keywords

Related Articles

Diabetes Mellitus is Frequent, But Retinopathy is Rare in Acromegaly: A Cross-sectional Study

Background: The roles of growth hormone (GH) and insulin-like growth factor-1 (IGF-1) in diabetic retinopathy (DR) are well recognized, but the prevalence and pathogenesis of retinopathy in acromegaly are not fully under...

A Rare Complication in a Peritoneal Dialysis Patient: Hydrothorax in Late Period

Peritoneal dialysis (PD) associated hydrothorax is a rare complication caused by leakage of dialysis fluid from the peritoneal cavity into the pleural space. The typical clinical presentation is a right-sided pleural eff...

Prognosis and Risks for Renal Transplant Recipients During the COVID-19 Pandemic

Background: We aim to compare potential factors that may affect the prognosis of kidney transplant recipients (KTRs) and hemodialysis patients (HDPs) with the diagnosis of COVID-19. Method: This single-center retrospect...

Musculoskeletal and Neurological Examination Findings in Post-COVID-19

Background: This study investigated the musculoskeletal and neurological examination findings in symptomatic patients who had previously experienced COVID-19. Material and Methods: A prospective cohort of 101 patients...

Prognostic Value of Systemic Immune Inflammation Index in Malignant Ischemic Stroke: A Study on Patient Selection and Timing of Surgical Decompression

Background: Ischemic stroke is a substantial health concern with long-term neurological consequences and economic implications. Inflammation worsens secondary brain injury, prompting the search for prognostic biomarkers....

Download PDF file
  • EP ID EP751150
  • DOI https://doi.org/10.5281/zenodo.10654236
  • Views 23
  • Downloads 0

How To Cite

Özgür Can University of Health Sciences, Istanbul Haydarpaşa Numune Training and Research Hospital, Department of Nephrology, Istanbul, Turkey https://orcid. org/0000-0001-8720-1400 (2024). Dyslipidemia and Kidney: An Updated View. Journal of European Internal Medicine Professionals (JEIMP), 2(1), -. https://europub.co.uk./articles/-A-751150